Technology ❯ Biotechnology

Drug Development

Clinical Trials Antiviral Drugs GLP-1 Agonists Computational Methods NaV1.8 Inhibitors MorphoSys Clinical Applications Immunotherapies Press Releases Neuroscience Peptide Therapies Antivenom Production Antivenom Research Biosimilars Natural Products Cancer Drugs Therapeutic Techniques Combination Therapy Non-Hormonal Contraceptives Peptide Therapy Synthetic Biology Innovations RNA Therapeutics Computational Chemistry Laboratory Infrastructure Targeted Therapies Innovative Therapies High-Throughput Screening

Johnson & Johnson to Buy Halda Therapeutics for $3.05 Billion to Bolster Oncology Pipeline

The deal would bring Halda’s RIPTAC technology plus prostate cancer pill HLD-0915 under J&J pending antitrust clearance.

Merck to Buy Cidara for $9.2 Billion to Secure Long-Acting Flu Drug

Tubulis Raises €308 Million Series C to Accelerate Lead Cancer ADC

CUNY Study Unveils Sugar-Targeting Compounds With Broad Antiviral Activity

Mix-and-Go Cubosome Method Achieves Over 98% mRNA Encapsulation and Advances Toward Clinical Scale-Up

Astrocyte-Derived Peptide Achieves Nausea-Free Weight Loss in Animal Models

Researchers Transform Ancient Tomb Fungus Into Potent Antileukemia Compound